These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 35416917)
1. Usefulness of Noninvasive Management With the Gutter Method for Epidermal Growth Factor Receptor Inhibitor-Induced Paronychia, Pyogenic Granuloma-Like Lesion, and Ingrown Nail. Agematsu A; Kamata M; Namiki K; Yabuuchi Y; Nagata M; Tada Y JAMA Dermatol; 2022 May; 158(5):583-585. PubMed ID: 35416917 [TBL] [Abstract][Full Text] [Related]
2. Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study. Yen CF; Hsu CK; Yang HS; Lee CN; Chi CC; Chung WH; Wang CL; Pang JS; Wang CW; Ko YS; Lu CW Int J Dermatol; 2020 Mar; 59(3):326-332. PubMed ID: 31763692 [TBL] [Abstract][Full Text] [Related]
3. Case series showing the efficacy of 5-aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor-induced paronychia and pyogenic granuloma-like lesions. Panariello L; Donnarumma M; Cinelli E; Fabbrocini G Br J Dermatol; 2019 Mar; 180(3):676-677. PubMed ID: 30298920 [No Abstract] [Full Text] [Related]
4. Topical betaxolol for treating relapsing paronychia with pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors. Yen CF; Hsu CK; Lu CW J Am Acad Dermatol; 2018 Jun; 78(6):e143-e144. PubMed ID: 29339238 [No Abstract] [Full Text] [Related]
5. Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. Bouscarat F; Bouchard C; Bouhour D N Engl J Med; 1998 Jun; 338(24):1776-7. PubMed ID: 9625645 [No Abstract] [Full Text] [Related]
6. Drug-related nail disease. Piraccini BM; Alessandrini A Clin Dermatol; 2013; 31(5):618-26. PubMed ID: 24079591 [TBL] [Abstract][Full Text] [Related]
7. Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitors. Sibaud V; Dalenc F; Mourey L; Chevreau C Acta Derm Venereol; 2011 Sep; 91(5):584-5. PubMed ID: 21667012 [No Abstract] [Full Text] [Related]
8. Case reports: mitozantrone-induced onycholysis associated with subungual abscesses, paronychia, and pyogenic granuloma. Freiman A; Bouganim N; O'Brien EA J Drugs Dermatol; 2005; 4(4):490-2. PubMed ID: 16004024 [TBL] [Abstract][Full Text] [Related]
9. Paronychia and granulation tissue formation during treatment with isotretinoin. Figueiras Dde A; Ramos TB; Marinho AK; Bezerra MS; Cauas RC An Bras Dermatol; 2016 Apr; 91(2):223-5. PubMed ID: 27192525 [TBL] [Abstract][Full Text] [Related]
10. Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan. Liu HL; Chuang CH; Chen CL; Wei PJ; Yang CJ J Oncol Pharm Pract; 2023 Sep; 29(6):1374-1380. PubMed ID: 36112905 [TBL] [Abstract][Full Text] [Related]
11. Gutter method: noninvasive management of ingrown nails caused by epidermal growth factor inhibitor treatment. Harada K; Yamaguchi M; Miyajima S; Kawamura T; Shibagaki S; Shimada S Clin Exp Dermatol; 2012 Aug; 37(6):703-4. PubMed ID: 22548530 [No Abstract] [Full Text] [Related]
12. Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited. Sass JO; Jakob-Sölder B; Heitger A; Tzimas G; Sarcletti M Dermatology; 2000; 200(1):40-2. PubMed ID: 10681612 [TBL] [Abstract][Full Text] [Related]
13. Indinavir-related recurrent paronychia and ingrown toenails. Alam M; Scher RK Cutis; 1999 Oct; 64(4):277-8. PubMed ID: 10544885 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature. Sollena P; Mannino M; Tassone F; Calegari MA; D'Argento E; Peris K Drugs Context; 2019; 8():212613. PubMed ID: 31798664 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail. Paul LJ; Cohen PR J Drugs Dermatol; 2012 Feb; 11(2):262-8. PubMed ID: 22270214 [TBL] [Abstract][Full Text] [Related]
16. Safety and long-term efficacy of partial matricectomy and phenolization for the treatment of pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors. Mariano M; Lorenzi S; De Padova MP; Fabbrocini G; Cameli N G Ital Dermatol Venereol; 2020 Aug; 155(4):517-518. PubMed ID: 30249089 [No Abstract] [Full Text] [Related]
17. Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study. Lu CW; Wang TY; Yen CF; Chen KH; Wu CE; Wang CL; Hsu PC; Fang YF; Li SH; Ko HW; Tseng LC; Shih FY; Lin YJ; Chen MJ; Chen CB; Su Pang JH; Chung WH; Ko YS Int J Dermatol; 2021 Feb; 60(2):179-184. PubMed ID: 32975313 [TBL] [Abstract][Full Text] [Related]
18. Keloid formation on the great toe after chronic paronychia secondary to ingrown nail. Lee KW; Burm JS; Yang WY Int Wound J; 2013 Apr; 10(2):200-2. PubMed ID: 23506345 [TBL] [Abstract][Full Text] [Related]
19. Kinesiology tapes wrapping for paronychia induced by epidermal growth factor receptor inhibitors: A pilot study. Hsu TJ; Yeh HH; Liu KL Dermatol Ther; 2022 Jun; 35(6):e15463. PubMed ID: 35307912 [No Abstract] [Full Text] [Related]
20. [Ingrown nail: A new cause of chronic perionyxis]. Chiheb S; Richert B; Belyamani S; Benchikhi H Ann Dermatol Venereol; 2010 Oct; 137(10):645-7. PubMed ID: 20932446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]